Vivalyx Revolutionizes Organ Preservation with €5.4M Funding
May 1, 2024, 9:32 pm
Vivalyx, a biotech company shaking up the organ preservation game, has secured a hefty €5.4M in Seed funding. This cash injection will fuel crucial clinical trials and kickstart commercialization efforts.
Donor organ scarcity is a pressing issue in the medical world, with traditional preservation methods falling short. Vivalyx steps in with their game-changing solution, Vivalyx Omnisol, a synthetic liquid that outperforms blood-based alternatives in preclinical trials. This innovation opens the door to scalable body-temperature perfusion, slashing costs and eliminating blood-related risks.
Founded by visionaries Dr. Andreas Schumacher and Dr. Benedict Doorschodt, along with a stellar team of co-founders, Vivalyx is poised to disrupt the organ transplantation industry. Their cutting-edge technology promises to breathe new life into donor organs, potentially saving countless lives.
With a consortium of investors backing their mission, Vivalyx is on the fast track to revolutionizing organ preservation worldwide. Stay tuned as this groundbreaking company paves the way for a brighter future in the realm of life-saving transplants.
Donor organ scarcity is a pressing issue in the medical world, with traditional preservation methods falling short. Vivalyx steps in with their game-changing solution, Vivalyx Omnisol, a synthetic liquid that outperforms blood-based alternatives in preclinical trials. This innovation opens the door to scalable body-temperature perfusion, slashing costs and eliminating blood-related risks.
Founded by visionaries Dr. Andreas Schumacher and Dr. Benedict Doorschodt, along with a stellar team of co-founders, Vivalyx is poised to disrupt the organ transplantation industry. Their cutting-edge technology promises to breathe new life into donor organs, potentially saving countless lives.
With a consortium of investors backing their mission, Vivalyx is on the fast track to revolutionizing organ preservation worldwide. Stay tuned as this groundbreaking company paves the way for a brighter future in the realm of life-saving transplants.